Research Group Polzin

Univ.-Prof. Dr. med. Amin Polzin

Topics

We combine analyses of lipids, thrombosis and metabolism in acute myocardial infarction, heart failure and structural heart disease. The mission of our group is to gain a detailed understanding of the interplay between metabolism, lipids and coagulation in cardiovascular disease in order to identify targets for primary and secondary prevention. Our aim is to translate these targets into clinical medicine.

Leading Team

Clinician Scientists

PhD Students

MD Students

  • Laura Wildeis
  • Jana Dahlmanns
  • Paulina Kahmann
  • Hannah Kowalski
  • Anja Zheng
  • Justus Ziese
  • Amelie Utz
  • Sophie Cremer

Collaborators

  • Univ.-Prof. Dr. med. B. Levkau (Heinrich-Heine-University Düsseldorf)
  • Univ.-Prof. Dr. med. R. Ahrends (University Wien)
  • Prof. Dr. rer. nat. J. Mitchell (Imperial College London)
  • PD Dr. med. Tobias Petzold (Charité Berlin)


Selected publications

  • Quast C, Bönner F, Polzin A, Veulemans V, Chennupati R, Gyamfi Poku I, Pfeiler S, Kramser N, Nankinova M, Staub N, Zweck E, Jokiel J, Keyser F, Hoffe J, Witkowski S, Becker K, Leuders P, Zako S, Erkens R, Jung C, Flögel U, Wang T, Neidlin M, Steinseifer U, Niepmann ST, Zimmer S, Gerdes N, Cortese-Krott MM, Feelisch M, Zeus T, Kelm M. Aortic Valve Stenosis Causes Accumulation of Extracellular Hemoglobin and Systemic Endothelial Dysfunction. Circulation. 2024 Jun
  • Møller JE, Engstrøm T, Jensen LO, Eiskjær H, Mangner N, Polzin A, Schulze PC, Skurk C, Nordbeck P, Clemmensen P, Panoulas V, Zimmer S, Schäfer A, Werner N, Frydland M, Holmvang L, Kjærgaard J, Sørensen R, Lønborg J, Lindholm MG, Udesen NLJ, Junker A, Schmidt H, Terkelsen CJ, Christensen S, Christiansen EH, Linke A, Woitek FJ, Westenfeld R, Möbius-Winkler S, Wachtell K, Ravn HB, Lassen JF, Boesgaard S, Gerke O, Hassager C; DanGer Shock Investigators. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med. 2024 Apr
  • Polzin A, Dannenberg L, Benkhoff M, Barcik M, Helten C, Mourikis P, Ahlbrecht S, Wildeis L, Ziese J, Zikeli D, Metzen D, Hu H, Baensch L, Schröder NH, Keul P, Weske S, Wollnitzke P, Duse D, Saffak S, Cramer M, Bönner F, Müller T, Gräler MH, Zeus T, Kelm M, Levkau B. Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction. Nat Commun. 2023 Apr
  • Thienel M, Müller-Reif JB, Zhang Z, Ehreiser V, Huth J, Shchurovska K, Kilani B, Schweizer L, Geyer PE, Zwiebel M, Novotny J, Lüsebrink E, Little G, Orban M, Nicolai L, El Nemr S, Titova A, Spannagl M, Kindberg J, Evans AL, Mach O, Vogel M, Tiedt S, Ormanns S, Kessler B, Dueck A, Friebe A, Jørgensen PG, Majzoub-Altweck M, Blutke A, Polzin A, Stark K, Kääb S, Maier D, Gibbins JM, Limper U, Frobert O, Mann M, Massberg S, Petzold T. Immobility-associated thromboprotection is conserved across mammalian species from bear to human. Science. 2023 Apr
  • Petzold T, Zhang Z, Ballesteros I, Polzin A, Saleh I, Weber C, Thienel M, Nicolai L, Pircher J, Mertsch P, Götschke J, Fu W, Fan S, Lorenz M, Ishikawa-Ankerhold H, El Menr S, Görlcah A, Marhuenda E, Schulz C, Stegner D, Gieger C, Gaertner F, Almendros I, Hidalgo A, Massberg S. Neutrophil-driven thrombopoiesis instigates cardiovascular risk. Immunity 2022 Dec
  • Polzin A, Dannenberg L, Benkhoff M, Barcik M, Keul P, Helten C, Zeus T, Kelm M, Levkau B. S1P Lyase Inhibition Starting After Ischemia/Reperfusion Improves Postischemic Cardiac Remodeling. JACC Basic Transl Sci. 2022 May 
  • Piayda K, Phinicarides R, Afzal S, Veulemans V, Jung C, Bönner F, Kelm M, Hellhammer K, Polzin A, Zeus T. Dynamic Coronary Roadmap in Percutaneous Coronary Intervention: Results From an Open-Label, Randomized Trial. JACC Cardiovasc Interv. 2021 Nov
  • Petzold T, Thienel M, Dannenberg L, Mourikis P, Helten C, Ayhan A, M'Pembele R, Achilles A, Trojovky K, Konsek D, Zhang Z, Regenauer R, Pircher J, Ehrlich A, Lüsebrink E, Nicolai L, Stocker TJ, Brandl R, Röschenthaler F, Strecker J, Saleh I, Spannagl M, Mayr CH, Schiller HB, Jung C, Gerdes N, Hoffmann T, Levkau B, Hohlfeld T, Zeus T, Schulz C, Kelm M, Polzin A. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1. Circulation Research. 2020 Feb
  • Keul P, Polzin A, Kaiser K, Gräler M, Dannenberg L, Daum G, Heusch G, Levkau B. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy. FASEB J. 2018 Aug 
  • Achilles A, Mohring A, Dannenberg L, Grandoch M, Hohlfeld T, Fischer JW, Levkau B, Kelm M, Zeus T, Polzin A. Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation. Journal of thrombosis and haemostasis 2017 Feb
  • Polzin A, Zeus T, Schror K, Kelm M, Hohlfeld T. Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. Journal of the American College of Cardiology 2013 Aug
MediathekInformation und Wissen
LageplanSo finden Sie uns